used Gretel's synthetic-data platform to create safe synthetic genomic datasets, enabling genomics research and safe/private data sharing between researchers, healthcare providers and industry

used Gretel's synthetic-data platform to create safe synthetic genomic datasets, enabling genomics research and safe/private data sharing between researchers, healthcare providers and industry

Gretel is a synthetic-data generation platform (acquired by NVIDIA) used to create privacy-preserving stand-ins for sensitive genomic and patient data.

This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.